Synaptogenic protein tagged with biotin and reconstitution of artificial synapse by using same

US2016137707A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016137707-A1
Application numberUS-201314786908-A
CountryUS
Kind codeA1
Filing dateAug 19, 2013
Priority dateApr 24, 2013
Publication dateMay 19, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed is a polypeptide containing an extracellular domain of a synaptogenic protein, and a method for manufacturing a nerve cell, a complex containing a biotin tagged at the C-terminus of the polypeptide, an artificial synapse inducer for coupling the composite to a streptavidin (SAV)-coated substrate and a nerve cell. The complex tagged with a biotin at the C-terminus of the polypeptide containing the extracellular domain of the synaptogenic protein, such as neuroligin-1, can display activity by being attached to the SAV-coated substrate to adjust the orientation thereof without help of a supported lipid bilayer. The complex containing an additional RFP between the extracellular domain and the biotin of the synaptogenic protein not only facilitates easier mass-production, quantification, and tracking, but also displays activity of a normal synaptogenic protein, thereby inducing excitatory or inhibitory synaptic differentiation by being fixed to the substrate and added to the nerve cell culture.

First claim

Opening claim text (preview).

1 . A complex comprising a polypeptide comprising an extracellular domain of a synaptogenic protein; and biotin tag at the C-terminus of the polypeptide. 2 . The complex of claim 1 , wherein the synaptogenic protein is selected from the group consisting of neuroligin, neurexin, leucine-rich repeat transmembrane protein (LRRTM), netrin G ligand (NGL), synaptic cell adhesion molecule (SynCAM), ephrin-B receptor (EphB), leukocyte common antigen-related protein (LAR), netrin G, and Slitrk (Slit- and Trk-like proteins). 3 . The complex of claim 1 , wherein the synaptogenic protein is neuroligin-1. 4 . The complex of claim 1 , further comprising a fluorescent protein in the order of the polypeptide comprising an extracellular domain of a synaptogenic protein, the fluorescent protein, and the biotin from a N-terminus thereof. 5 . The complex of claim 4 , wherein the fluorescent protein is red fluorescent protein (RFP). 6 . The complex of claim 1 , further comprising a polyhistidine-tag (His-tag) or influenza hemagglutinin epitope tag (HA-tag). 7 . An artificial synapse inducer, wherein the complex of claim 1 is attached to a substrate coated with a biotin-binding protein. 8 . The artificial synapse inducer of claim 7 , wherein the biotin-binding protein is selected from the group of avidin-like proteins consisting of streptavidin, traptavidin, and neutravidin. 9 . The artificial synapse inducer of claim 7 , wherein the substrate is a microbead. 10 . A method for preparing a presynaptic differentiation-induced neuron comprising culturing the neuron in a medium comprising the artificial synapse inducer of claim 7 . 11 . The method of claim 10 , wherein the presynaptic differentiation is an excitatory presynaptic differentiation or an inhibitory presynaptic differentiation. 12 . The artificial synapse inducer of claim 7 , wherein the synaptogenic protein is selected from the group consisting of neuroligin, neurexin, leucine-rich repeat transmembrane protein (LRRTM), netrin G ligand (NGL), synaptic cell adhesion molecule (SynCAM), ephrin-B receptor (EphB), leukocyte common antigen-related protein (LAR), netrin G, and Slitrk (Slit- and Trk-like proteins). 13 . The artificial synapse inducer of claim 7 , wherein the synaptogenic protein is neuroligin-1. 14 . The artificial synapse inducer of claim 7 , wherein the complex further comprises a fluorescent protein in the order of the polypeptide comprising an extracellular domain of a synaptogenic protein, the fluorescent protein, and the biotin from a N-terminus thereof. 15 . The artificial synapse inducer of claim 14 , wherein the fluorescent protein is red fluorescent protein (RFP). 16 . The artificial synapse inducer of claim 7 , wherein the complex further comprises a polyhistidine-tag (His-tag) or influenza hemagglutinin epitope tag (HA-tag).

Assignees

Inventors

Classifications

  • C07K14/705Primary

    Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)} · CPC title

  • containing a tag for immunodetection, or an epitope for immunisation · CPC title

  • Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor · CPC title

  • containing a motif for post-translational modification · CPC title

  • Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016137707A1 cover?
Disclosed is a polypeptide containing an extracellular domain of a synaptogenic protein, and a method for manufacturing a nerve cell, a complex containing a biotin tagged at the C-terminus of the polypeptide, an artificial synapse inducer for coupling the composite to a streptavidin (SAV)-coated substrate and a nerve cell. The complex tagged with a biotin at the C-terminus of the polypeptide co…
Who is the assignee on this patent?
Univ Seoul Nat R & Db Found
What technology area does this patent fall under?
Primary CPC classification C07K14/705. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).